An analysis of TP53 mutations in the ctDNA showed that the number of detected gene copies was correlated with the volume of relapsed tumor, and a decrease of less than 60% in the TP53 mutant allele fraction after chemotherapy was associated with poor response and shorter time to progression [268]. Here, TP53 is linked to neoplasm.